Company InformationMammoth Biosciences was founded on January 2017. The company is based in San Francisco, CA, USA . The number of employees in Mammoth Biosciences is less than 50. Mammoth biosciences is a developer of a crispr-based disease detection platform.
Funding & investorsMammoth Biosciences has received 4 rounds of venture funding. The total funding amount is around $68.1M.
- Decheng Capital (Venture capital)
- Brook Byers (Investment partner)
- Pacific 8 Ventures (Venture capital)
- aMoon Fund (Angel group)
- Plum Alley (Micro vc)
- Contact us if you are interested to see all 12 investors
Similar Companies [beta]
Active Venture Investors
- Active Investors in Biotechnology
- Active Investors in Data And Analytics
- Active Investors in Health Care
- Active Investors in Science And Engineering
- Active Investors in Wellness
- Best Funded Biotechnology Startups
- Best Funded Data And Analytics Startups
- Best Funded Health Care Startups
- Best Funded Science And Engineering Startups
- Best Funded Wellness Startups
Mammoth Biosciences - Blog
- Knocking out, writing, and modulating DNA with CRISPR
- Mammoth’s top tweets of 2021!
- Mammoth’s top 5 blog posts of 2021
- “Movember” Men’s Mental Health Awareness Event at Mammoth
- DEI initiatives at Mammoth – Portraits of scientists from underrepresented backgrounds
- Using CRISPR to overcome the challenges of in vivo genome editing
We’ve talked a lot about genome editing on the Mammoth blog, but there are actually many different forms genome editing can take. That is, we can make different kinds of changes to DNA depending upon what kinds of CRISPR systems and techniques we use. Indeed, different types of genome editing are more or less appropriate […]The post Knocking out, writing, and modulating DNA with CRISPR appeared first on Mammoth Biosciences.
Our twitter following grew quite dramatically in 2021. Over the last 12 months, we’ve grown from ~3,200 followers to ~4,550 followers! In this post, we celebrate some of our favorite tweets from 2021. At Mammoth, we use twitter to share resources covering CRISPR, genome editing, diagnostics, infectious disease, diversity in STEM, Mammoth news, and more. […]The post Mammoth’s top tweets of 2021! appeared first on Mammoth Biosciences.
Before the start of the new year, we’re continuing a tradition on the Mammoth blog and taking a look back at some of our favorite posts! Although not all of these posts were published this year, they were all highly viewed. All of these posts also provide insights into important aspects of CRISPR genome editing, […]The post Mammoth’s top 5 blog posts of 2021 appeared first on Mammoth Biosciences.
This past November, the Justice, Equity, Diversity, and Inclusion (JEDI) and Team, Unity, Social, and Cultural (TUSC) committees at Mammoth organized a “Movember” event. As part of this event, individuals grew mustaches throughout November to raise awareness for men’s mental health issues. At Mammoth, we participated in Movember with the objective of raising awareness, fostering […]The post “Movember” Men’s Mental Health Awareness Event at Mammoth appeared first on Mammoth Biosciences.
At Mammoth, we recognize that systemic racism and historical injustices have led to a lack of diversity in the sciences. One of our goals is to combat this injustice by making diversity, equity, and inclusion an integral part of our culture. To do so, our Justice, Equity, Diversity and Inclusion (JEDI) committee undertakes projects aimed […]The post DEI initiatives at Mammoth – Portraits of scientists from underrepresented backgrounds appeared first on Mammoth Biosciences.
Genome editing has many applications in basic research, bioproduction, agriculture, and more. In this post, we focus on the promise of “in vivo” genome editing in healthcare. We previously covered “ex vivo” genome editing. This involves editing cells’ DNA in the lab and delivering the cells to patients. The edited cells might replace unhealthy cells […]The post Using CRISPR to overcome the challenges of in vivo genome editing appeared first on Mammoth Biosciences.